Sentinel lymph node procedure
| Point of injection; n (%) | 95% CI | |
| Utero-ovarian ligament stump | ||
| Not applicable (HT performed) | 5 (25) | – |
| Unilateral | 14 (70) | – |
| Bilateral | 1 (5) | – |
| Utero-ovarian ligament migration (n15) | ||
| No | 1 (6.7) | – |
| Unilateral | 13 (86.7) | – |
| Bilateral | 1 (6.7) | – |
| Infundibulopelvic ligament stump | ||
| Unilateral | 19 (95) | – |
| Bilateral | 1 (5) | – |
| Infundibulopelvic ligament migration (n20) | ||
| No | 0 (0) | – |
| Unilateral | 16 (80) | – |
| Bilateral | 4 (20) | – |
| SLN detection rate; n (%) | ||
| Pelvic (n15) | 14 (93.3) | 66% to 100% |
| Paraortic (n20) | 20 (100) | 80% to 100% |
| Pelvic and para-aortic | 19 (95) | 73% to 100% |
| Pelvic and/or para-aortic | 20 (100) | 80% to 100% |
| SLN detection method; n (%) | ||
| Intra-operative lymphography | 1 (5) | 0% to 27% |
| Tc 99m | 20 (100) | 80% to 100% |
| ICG | 19 (95) | 73% to 100% |
| Both (Tc 99m+ ICG) | 20 (100) | 80% to 100% |
| Time after injection [Mean±SD (Range)]; min | 53±15 (30–80) | 46.5 to 60.8 min |
HT, hysterectomy; ICG, Indocyanine green; SLN, sentinel lymph node.